Visual Field Defect clinical trials
9 active trials name this condition. Describe your situation to see which ones you may be eligible for.
- Improving Visual Field Deficits With Noninvasive Brain Stimulation
- PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery
- Visual Plasticity Following Brain Lesions
- Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease
- Home-based Vision Rehabilitation Guided by Brain Imaging
- Feasibility Tests for Various Prism Configurations for Visual Field Loss
- Vision Loss Impact on Navigation in Virtual Reality
- Visual Restoration Using Focused Ultrasound Stimulation and Immersive Virtual Reality After Stroke
- Statistical Learning as a Novel Intervention for Cortical Blindness
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Visual Field Defect” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.